{
    "organizations": [],
    "uuid": "593bf8dd4b6f295d3207197a0f9e8acef1119554",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novartis-patients-on-entresto-repo/brief-novartis-patients-on-entresto-report-improved-quality-of-life-idUSFWN1SZ0GO",
    "ord_in_thread": 0,
    "title": "BRIEF-Novartis: patients on Entresto report improved quality of life",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 28 (Reuters) - Novartis AG:\n* NOVARTIS INTERNATIONAL AG: PATIENT-REPORTED OUTCOMES TOOL REVEALED SIGNIFICANT IMPROVEMENT IN SYMPTOM FREQUENCY AND QUALITY OF LIFE DOMAINS WITH ENTRESTO\n* SAYS OVERALL SUMMARY SCORE WAS ALSO SIGNIFICANTLY HIGHER FOR ENTRESTO PATIENTS THAN FOR PATIENTS NOT TAKING ENTRESTO Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)\n ",
    "published": "2018-05-28T22:38:00.000+03:00",
    "crawled": "2018-05-30T11:22:01.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "novartis",
        "ag",
        "novartis",
        "international",
        "ag",
        "outcome",
        "tool",
        "revealed",
        "significant",
        "improvement",
        "symptom",
        "frequency",
        "quality",
        "life",
        "domain",
        "entresto",
        "say",
        "overall",
        "summary",
        "score",
        "also",
        "significantly",
        "higher",
        "entresto",
        "patient",
        "patient",
        "taking",
        "entresto",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "zurich",
        "newsroom"
    ]
}